Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Human CTAG2 Polyclonal Antibody

Catalog #:   PHB27501 Specific References (26) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: O75638
Overview

Catalog No.

PHB27501

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human CTAG2 (Leu87-Asp141).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Cancer/testis antigen 2, CT2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, CT6.2, L antigen family member 1, LAGE-1, CTAG2, ESO2, LAGE1

Purification

Purified by antigen affinity column.

Accession

O75638

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with CTAG2 antibody (PHB27501) at 1 µg/ml.

    Lane 1: Recombinant Protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 34 kDa
    Observed MW: 34 kDa
References

Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer., PMID:38309723

Specific Inhibition of Tumor Growth by T Cell Receptor-Drug Conjugates Targeting Intracellular Cancer-Testis Antigen NY-ESO-1/LAGE-1., PMID:33237767

Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation., PMID:29473162

Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection., PMID:28800944

The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions., PMID:28768706

Autoantibody biomarkers for the detection of serous ovarian cancer., PMID:28427776

Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade., PMID:27294163

Plasma Autoantibodies Associated with Basal-like Breast Cancers., PMID:26070530

Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigens., PMID:24604332

Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma., PMID:24457462

MAGE-A3 is highly expressed in a subset of colorectal cancer patients., PMID:23390371

Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors., PMID:23263452

Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy., PMID:21247062

Yeast-based identification of prostate tumor antigens provides an effective vaccine platform., PMID:20393012

Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays., PMID:19041653

Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue., PMID:15756003

[Expression of NY-ESO-1/LAGE-1 genes in hepatocellular carcinoma and autologous humoral responses induced thereby]., PMID:15730810

Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1., PMID:15623618

Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer., PMID:15516106

Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display., PMID:14747957

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy., PMID:14738769

Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer., PMID:14680360

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer., PMID:14522938

Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients., PMID:12932233

A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved., PMID:12384295

LAGE-1, a new gene with tumor specificity., PMID:9626360

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human CTAG2 Polyclonal Antibody [PHB27501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only